Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Yeastup AG

History from 26 May 2020

UID
CHE-430.369.216
Legal form
AG
Canton
AG
Founded
26 May 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 340k
85k170k255k340k29 Jan 2021 · CHF 167k18 Mar 2022 · CHF 190k3 Jul 2023 · CHF 227k27 Dec 2024 · CHF 314k22 Sep 2025 · CHF 340k20212022202320242025
  • shares
  • Vorzugsaktien (Seed
  • Vorzugsakten (Serie A
  • Vorzugsaktien (Serie A
  • Vorzugsaktien (Series A

Record

  1. Company formed

    Founded 26 May 2020

    SHAB HR01-1004899814 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    150’000 → 166’700
    Shares
    150’000 → 166’700
    New shares, % of post-step shares
    10.0% (16’700 new)

    Aktienkapital neu: CHF 166'700.00 [bisher: CHF 150'000.00]. Liberierung Aktienkapital neu: CHF 166'700.00 [bisher: CHF 150'000.00]. Aktien neu: 166'700 Namenaktien zu CHF 1.00 [bisher: 150'000 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung vom 13.11.2020 / 22.01.2021.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005087387 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    166’700 → 190’451
    Shares
    166’700 → 190’451
    New shares, % of post-step shares
    12.5% (23’751 new)

    Aktienkapital neu: CHF 190'451.00 [bisher: CHF 166'700.00]. Liberierung Aktienkapital neu: CHF 190'451.00 [bisher: CHF 166'700.00]. Aktien neu: 190'451 Namenaktien zu CHF 1.00 [bisher: 166'700 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung vom 18.02.2022.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005430530 ↗
  4. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    190’451 → 226’938
    Shares
    190’451 → 226’938
    New shares, % of post-step shares
    16.1% (36’487 new)
    Share classes
    132’000 × CHF 1 · 58’451 × CHF 1 Vorzugsaktien (Seed · 36’487 × CHF 1 Vorzugsakten (Serie A

    Aktienkapital neu: CHF 226'938.00 [bisher: CHF 190'451.00]. Liberierung Aktienkapital neu: CHF 226'938.00 [bisher: CHF 190'451.00]. Aktien neu: 132'000 Namenaktien zu CHF 1.00, 58'451 Namenaktien zu CHF 1.00 (Vorzugsaktien (Seed)) und 36'487 Namenaktien zu CHF 1.00 (Vorzugsakten (Serie A)) [bisher: 190'451 Namenaktien zu CHF 1.00]. [Streichung der Statutenbestimmung über die genehmigte Kapitalerhöhung.] [gestrichen: Die Generalversammlung hat mit Beschluss vom 15.06.2022 eine genehmigte Kapitalerhöhung gemäss näherer Umschreibung in den Statuten beschlossen.]. Die Gesellschaft hat mit Beschluss vom 15.06.2023 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005784801 ↗
  5. Capital band adopted

    SHAB HR02-1005784801 ↗
  6. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    226’938 → 313’598
    Shares
    226’938 → 313’598
    New shares, % of post-step shares
    27.6% (86’660 new)
    Share classes
    132’000 × CHF 1 · 58’451 × CHF 1 Vorzugsaktien (Seed · 123’147 × CHF 1 Vorzugsaktien (Serie A

    Aktienkapital neu: CHF 313'598.00 [bisher: CHF 226'938.00]. Liberierung Aktienkapital neu: CHF 313'598.00 [bisher: CHF 226'938.00]. Aktien neu: 132'000 Namenaktien zu CHF 1.00, 58'451 Namenaktien zu CHF 1.00 (Vorzugsaktien (Seed)) und 123'147 Namenaktien zu CHF 1.00 (Vorzugsaktien (Serie A)) [bisher: 58'451 Namenaktien zu CHF 1.00 (Vorzugsaktien (Seed)), 36'487 Namenaktien zu CHF 1.00 (Vorzugsakten (Serie A)) und 132'000 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands vom 13.12.2024.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006217012 ↗
  7. Capital band adopted

    SHAB HR02-1006400071 ↗
  8. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    313’598 → 339’610
    Shares
    313’598 → 339’610
    New shares, % of post-step shares
    7.7% (26’012 new)
    Share classes
    132’000 × CHF 1 · 58’451 × CHF 1 Vorzugsaktien (Seed · 149’159 × CHF 1 Vorzugsaktien (Series A

    Aktienkapital neu: CHF 339'610.00 [bisher: CHF 313'598.00]. Liberierung Aktienkapital neu: CHF 339'610.00 [bisher: CHF 313'598.00]. Aktien neu: 132'000 Namenaktien zu CHF 1.00, 58'451 Namenaktien zu CHF 1.00 (Vorzugsaktien (Seed)) und 149'159 Namenaktien zu CHF 1.00 (Vorzugsaktien (Series A)) [bisher: 132'000 Namenaktien zu CHF 1.00, 58'451 Namenaktien zu CHF 1.00 (Vorzugsaktien (Seed)) und 123'147 Namenaktien zu CHF 1.00 (Vorzugsaktien (Serie A))]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.90 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006438920 ↗

Published by 28 Sep 2025

Latest available record · 8 Oct 2026